Keyword: Department of Health and Human Services (HHS)
Pfizer became the center of a drug pricing controversy this summer and delayed dozens of price hikes. Now it's ready to raise prices again in January.
Who wants drug prices in ads? Older people, that’s who.
Tuesday's midterm results already brought a dose of new promises to tackle drug prices. But that’s not the only headache pharma faces in the House.
If Republicans can keep the Senate on Tuesday, the pharma industry will likely dodge meaningful pricing reform, according to two experts.
It's no secret that drug prices are higher in the U.S. than in other countries, and now the Trump administration appears poised to act.
Pharma might have thought it could fend off the Trump administration's bid to get drug prices into consumer advertising, but it was wrong.
From pharma exec to attorney general? HHS Secretary Alex Azar is on a list of candidates to replace Jeff Sessions if he resigns, the WSJ reports.
Sticker prices in drug ads might be off the table again, thanks to some in the U.S. House of Representatives.
After HHS proposed a rule that would shake up or eliminate drug rebates, a watchdog wants to know if agency chief Alex Azar has ulterior motives.
The Senate voted in favor of drug pricing in DTC ads, while HHS works on a transparency proposal for Medicare and Medicaid.